Eleni T. Timotheadou

Thessaloniki, ESYE12 56429, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Fagotti Score (FS) Compared with Peritoneal Cancer Index (PCI) for Preoperative Assessment of Optimal Cytoreduction in Upfront Laparoscopy.

Fagotti Score (FS) Compared with Peritoneal Cancer Index (PCI) for Preoperative Assessment of Optimal Cytoreduction in Upfront Laparoscopy.

Journal: Current oncology (Toronto, Ont.)

Published: April 14, 2026

Prognosis of Pregnancy-Associated Breast Cancer: A Systematic Review of Contemporary Observational Studies.

Prognosis of Pregnancy-Associated Breast Cancer: A Systematic Review of Contemporary Observational Studies.

Journal: Medical sciences (Basel, Switzerland)

Published: January 21, 2026

Prognostic Factors of Advanced Ovarian Cancer in the Era of HIPEC: A Multicenter Retrospective Study from an ESGO-Certified Center and an ESPSO-Certified Center.

Prognostic Factors of Advanced Ovarian Cancer in the Era of HIPEC: A Multicenter Retrospective Study from an ESGO-Certified Center and an ESPSO-Certified Center.

Journal: Biomedicines

Published: January 06, 2026

Characterizing Gynecological Cancers with the Uncommon dMMR/MSS Phenotype in Lynch Syndrome Patients.

Characterizing Gynecological Cancers with the Uncommon dMMR/MSS Phenotype in Lynch Syndrome Patients.

Journal: Journal of clinical medicine

Published: January 05, 2026

Comparison of Pelvic Peritonectomy vs. Rectosigmoid Resection During Hudson Procedure for Advanced Ovarian Cancer: 6-Year Experience of an ESGO-Certified Center.

Comparison of Pelvic Peritonectomy vs. Rectosigmoid Resection During Hudson Procedure for Advanced Ovarian Cancer: 6-Year Experience of an ESGO-Certified Center.

Journal: Cancers

Published: January 01, 2026

Prognostic Factors in the Treatment of Advanced Endometrial Cancer Patients: 12-Year Experience of an ESGO Certified Center.

Prognostic Factors in the Treatment of Advanced Endometrial Cancer Patients: 12-Year Experience of an ESGO Certified Center.

Journal: Cancers

Published: December 14, 2025

Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece-The TRINITY Study.

Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece-The TRINITY Study.

Journal: Cancers

Published: October 24, 2025

Dissecting the Non-Immune Tumor Microenvironment in Triple-Negative Breast Cancer: Molecular Subtype-Specific Patterns and Prognostic Implications.

Dissecting the Non-Immune Tumor Microenvironment in Triple-Negative Breast Cancer: Molecular Subtype-Specific Patterns and Prognostic Implications.

Journal: International journal of molecular sciences

Published: October 10, 2025

The Role of Delayed Interval Debulking Surgery (DIDS) in the Surgical Treatment of Advanced Epithelial Ovarian Cancer: A Retrospective Cohort from an ESGO-Certified Center.

The Role of Delayed Interval Debulking Surgery (DIDS) in the Surgical Treatment of Advanced Epithelial Ovarian Cancer: A Retrospective Cohort from an ESGO-Certified Center.

Journal: Medical sciences (Basel, Switzerland)

Published: August 27, 2025

The Impact of Treatment Delay on Endometrial and Ovarian Cancer Patients: A Systematic Review.

The Impact of Treatment Delay on Endometrial and Ovarian Cancer Patients: A Systematic Review.

Journal: Cancers

Published: May 28, 2025

Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer.

Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer.

Journal: Translational oncology

Published: May 26, 2025

Utilization of Ligasure® Maryland Jaw Open Sealer/Divider with Nanocoating Improves Perioperative Parameters in Women with Advanced Ovarian Cancer Subjected to Cytoreductive Surgery.

Utilization of Ligasure® Maryland Jaw Open Sealer/Divider with Nanocoating Improves Perioperative Parameters in Women with Advanced Ovarian Cancer Subjected to Cytoreductive Surgery.

Journal: Journal of clinical medicine

Published: May 16, 2025

Showing 1-12 of 65

Last Updated: 09/26/2026